After CD4+ T cells are mainly activated by activated DCs, they can directly recognize and kill MHC-II+ tumor cells as well as recruit and activate more NK cells, DCs, and CD8+ T cells, and enhance the tumor cell-killing ability of CTLs (20, 21). The gene discussed is CD8A; the disease is neoplasm.